Company · CIK 1954488
Jyong Biotech Ltd.
| CIK | 1954488 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Listed | MENS (Nasdaq) |
| First annual or quarterly report | 2026-05-15 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-277725 | 2024-03-07 | 2025-06-18 | 14 | |
| 333-274042 | 2023-08-17 | 2023-12-20 | 4 |
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-06-18 | 424B4Final prospectus | 333-277725 | 0001213900-25-055414 |
| 2025-06-16 | EFFECTDeclared effective | 333-277725 | 9999999995-25-001932 |
| 2025-03-31 | EFFECTDeclared effective | 333-277725 | 9999999995-25-000866 |
| 2025-03-11 | F-1/AAmendment | 333-277725 | 0001213900-25-022817 |
| 2025-02-06 | F-1/AAmendment | 333-277725 | 0001213900-25-010915 |
| 2024-12-19 | F-1/AAmendment | 333-277725 | 0001213900-24-110278 |
| 2024-11-21 | F-1/AAmendment | 333-277725 | 0001213900-24-100844 |
| 2024-11-01 | F-1/AAmendment | 333-277725 | 0001213900-24-093082 |
| 2024-10-04 | F-1/AAmendment | 333-277725 | 0001213900-24-085408 |
| 2024-09-16 | F-1/AAmendment | 333-277725 | 0001213900-24-078694 |
| 2024-08-02 | F-1/AAmendment | 333-277725 | 0001213900-24-064830 |
| 2024-06-21 | F-1/AAmendment | 333-277725 | 0001213900-24-054840 |
| 2024-05-08 | F-1/AAmendment | 333-277725 | 0001213900-24-040670 |
| 2024-03-07 | F-1Registration filed | 333-277725 | 0001213900-24-020570 |
| 2023-12-20 | RWWithdrawn | 333-274042 | 0001213900-23-097177 |
| 2023-12-05 | F-1/AAmendment | 333-274042 | 0001213900-23-093007 |
| 2023-10-18 | F-1/AAmendment | 333-274042 | 0001013762-23-004683 |
| 2023-08-17 | F-1Registration filed | 333-274042 | 0001213900-23-068470 |
| 2023-03-16 | DRSDraft made public | 377-06632 | 0001213900-23-020402 |